Testimonials

Clinical Trial Venowave

The initial clinical evaluation of the Venowave began in 2001 with the McMaster Thrombosis group, including Drs. Martin O’Donnell, Jack Hirsh, Jeff Ginsberg and Dr. Susan Kahn of McGill University, by examining a population of patients suffering from severe post thrombotic syndrome. In 2008 the final results were published, the most severely affected patients were able to remain mobile and improve their quality of life using the VW5.
To read the complete trial, click here.

Experiences dr. med. Richter-Hintz with EVRF

Read here (link is in German)

Dr. Seiter from the Seiter Klinik in Stuttgart about the EVRF

Read here (Link is in German)

Dr. Attila Szabó about the EVRF:

I have been using the EVRF device for a few months now, and I have very good experiences with it. The intraluminal catheter is very easy to use, the primary closure rate was 100 % at the first 10 patients, no one suffered from postoperative pain, and the cosmetic results were excellent.
The hand piece for Sclerotherapy made it possible to treat very small spider veins successfully, that were resistant for laser therapy. The treatment is almost painless, other minor advantages are, that there is no need for compression therapy after the procedure and that patients can be treated in the summer without problems too.

Thank you for the possibility.

Best wishes,

Dr. Attila Szabó Ph.D.
Assistant professor of vascular surgery
Semmelweis University Budapest Vascular Clinic

Dr. Sarah Thomis from the UZ Leuven about the EVRF:

EVRF is a wonderful technique for treating veins insufficiency. The Saphena Magna and Parva, as well as smaller reticular veins. This is a great advantage, since the correct amount of energy can be given per diameter to obtain the occlusion of the vein. And also shorter segments can be treated, as the tip of the catheter is only 0,5cm long. The catheter (CR45i) for the treatment of stamvarices is very smooth and easy to carry, even over a twist. The catheter lies good in de hand and with the roller system it´s easy to control. The dozens of patient treated here, were all satisfied with the result. We will soon launch a pilot study with 40 VSM´s. The focus will be on the Quality of Life score, pain score and occlusion rate.

Yours sincerely,

Dr. Sarah Thomis
Flebologe, Vascular Surgery Service
UZ Leuven

An enumeration contains the features and benefits of the EVRF ( EndoVenousRadioFrequency) device.

After years of research and development, during which we worked closely  together with dedicated specialists in  varicose vein  treatment around the world, Fcare Systems created a multi-disciplinary device on this matter, the EVRF. But how does the EVRF work and what are the benefits?
Read more

Link to German article about thermocoagulation

Dr. Elias is first one to use EVRF in the U.S.

Steve Elias, MD, FACS, FACPh, is among the first in the United States to use the new minimally invasive technology, EVRF.
Somewhat similar to Veinwave, EVRF can be used on collateral, perforating and reticular veins, as well as spider veins and varicose veins.
Radiofrequency energy, similar to microwave, is transmitted into the abnormal veins with a microprobe through the skin. The energy helps to seal the abnormal veins that eventually dissolve and get absorbed. The procedure is done in office and takes about 15 minutes. Patients can resume all activities after treatment including exercise.
Elias said the advantages  of the EVRF are that treatment can take place all year round; treatment can be used on all skin types; treatment has no side effects; the patient do not need to wear stockings after treatment; and there is no activity restrictions including exercise.
“This technology allows us to treat small veins and adds another tool to our existing techniques when treating these types of veins.” Dr. Elias explains, “As with all of our options, EVRF is complementary to others such as sclerotherapy and laser treatments.”
With EVRF and other treatments most patients see an improvement, not all veins disappear but the cosmetic results are significant.  Our goal is to offer patients the newest and most effective minimally invasive procedures.” – VTN